Predictive Oncology Launches Innovative Specialty Media for Growing Ovarian Tumors in the Lab

NEXT STORY
Generex Biotechnology Appoints Independent Director Carol Nacy, PhD to the NuGenerex Immuno-Oncology Board of Directors
PREV STORY
Update: Diomics Corp. Announces Development of Intellectual Property and Patents Related to the Identification of Airborne Pathogens
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Devonian Health Group Announces Canadian Patent for its Purgenesis™ anti-aging treatment

QUEBEC CITY, May 16, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. ("Devonian" or ...

author_avatar
NASDAQ Market News

Neovacs And Lupus Europe Join Voices On World Lupus Day

NEOVACS AND LUPUS EUROPE JOIN VOICES ON WORLD LUPUS DAY In order to raise ...

author_avatar
NASDAQ Market News

MacroGenics to Present at the Needham Healthcare Conference

Rockville, MD, March 29, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage ...

author_avatar
NASDAQ Market News